SG11201400696XA - Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes - Google Patents

Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Info

Publication number
SG11201400696XA
SG11201400696XA SG11201400696XA SG11201400696XA SG11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA SG 11201400696X A SG11201400696X A SG 11201400696XA
Authority
SG
Singapore
Prior art keywords
maltotriose
compositions
methods
same
damage caused
Prior art date
Application number
SG11201400696XA
Other languages
English (en)
Inventor
Zihua Ao
Juan M Gonzalez
Bradley J Taylor
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46846027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201400696X(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201400696XA publication Critical patent/SG11201400696XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201400696XA 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes SG11201400696XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/270,607 US20130089638A1 (en) 2011-10-11 2011-10-11 Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
PCT/US2012/053855 WO2013055463A1 (en) 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Publications (1)

Publication Number Publication Date
SG11201400696XA true SG11201400696XA (en) 2014-08-28

Family

ID=46846027

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201400696XA SG11201400696XA (en) 2011-10-11 2012-09-06 Compositions comprising maltotriose and methods of using same to inhibit damage caused by dehydration processes

Country Status (15)

Country Link
US (1) US20130089638A1 (es)
EP (1) EP2765872A1 (es)
CN (2) CN107647394A (es)
AR (1) AR088035A1 (es)
BR (1) BR112014008498A2 (es)
CA (1) CA2852109A1 (es)
CO (1) CO6940418A2 (es)
EC (1) ECSP14000460A (es)
HK (2) HK1199797A1 (es)
MX (1) MX2014004060A (es)
PE (1) PE20142080A1 (es)
RU (1) RU2014110708A (es)
SG (1) SG11201400696XA (es)
TW (2) TW201325460A (es)
WO (1) WO2013055463A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3369805B1 (en) 2015-10-30 2020-08-26 Kabushiki Kaisha Yakult Honsha Method for producing dried microbial cells
EP3524051A1 (en) * 2018-02-12 2019-08-14 DuPont Nutrition Biosciences ApS Matricial microencapsulation compositions

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792183A (en) * 1971-08-10 1974-02-12 Nabisco Inc Cereal coating composition and process
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US4814267A (en) * 1984-09-18 1989-03-21 Michigan Biotechnology Institute Method for preparing high conversion syrups and other sweeteners
DE68912719T2 (de) * 1988-11-10 1994-07-21 Takeda Chemical Industries Ltd Saure Urease-Zubereitungen für alkoholische Getränke.
US5145697A (en) * 1989-04-26 1992-09-08 Mpy Foods, Inc. Instant yogurt composition and process
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
AU661297B2 (en) 1991-01-24 1995-07-20 Martek Corporation Microbial oil mixtures and uses thereof
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
DK0729383T3 (da) 1993-11-17 2000-02-07 Niro Holding As Fremgangsmåde og forstøvningstørringsapparat til fremstilling af et agglomereret pulver
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
ATE298363T1 (de) * 1996-07-09 2005-07-15 Nestle Sa Verfahren zur sprühtrocknung
US6223455B1 (en) 1999-05-03 2001-05-01 Acusphere, Inc. Spray drying apparatus and methods of use
US6463675B1 (en) 1999-09-29 2002-10-15 Niro A/S Process and a plant for spray drying
US6322994B1 (en) * 1999-11-04 2001-11-27 Genetix Limited Method of freeze-drying organisms
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
FR2829147B1 (fr) * 2001-08-30 2003-12-12 Agronomique Inst Nat Rech Procede de preparation d'une composition lyophilisee contenant des bacteries lactiques a viabilite et activite bacteriennes ameliorees lors d'un stockage a temperature ambiante et composition obtenue
US6838097B1 (en) * 2001-12-14 2005-01-04 Stephen Tsengas Pet food product
NZ537706A (en) * 2002-06-28 2008-03-28 Puleva Biotech Sa Probiotic microbial strains, comprising non-pathogenic strains which are capable of surviving in and being transferred to breast milk and/or amniotic fluid after oral intake in healthy individuals without colonizing other internal organs except mucousas
WO2006029467A1 (en) * 2004-09-16 2006-03-23 Btf Pty Ltd Rapid freeze drying process
EP1656930A1 (en) 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
CN101080176B (zh) * 2004-12-21 2011-12-07 弗门尼舍有限公司 包封的多不饱和脂肪酸
KR101229855B1 (ko) * 2005-03-31 2013-02-05 미쓰비시 가가꾸 가부시키가이샤 열화 방지제
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
EP1967196A4 (en) * 2005-11-18 2009-10-14 Idemitsu Kosan Co CONTROL AGENT OF A TOXIC BACTERIUM CONTAINING BACILLUS THURINGIENSIS
JP4889317B2 (ja) * 2006-02-17 2012-03-07 オリエンタル酵母工業株式会社 マルトトリオース高含有組成物及びその製造方法
EP1903291A1 (en) 2006-09-19 2008-03-26 Ima-Telstar S.L. Method and system for controlling a freeze drying process
NZ585619A (en) * 2007-12-20 2012-06-29 Abbott Lab Nutritional powder composition comprising carbohydrate, lipid, hydrolysed whey and intact protein
WO2009108689A1 (en) * 2008-02-25 2009-09-03 Novavax, Inc. Sugar glassified virus like particles (vlps)
CN101313715A (zh) * 2008-07-09 2008-12-03 内蒙古蒙牛乳业（集团）股份有限公司 一种添加维生素适用于12到36个月的婴儿液态乳
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
RU2573324C2 (ru) * 2010-08-13 2016-01-20 Эдванст Байоньютришн Корпорейшн Стабилизирующая композиция для сухого хранения биологических материалов (варианты)

Also Published As

Publication number Publication date
HK1199797A1 (en) 2015-07-24
PE20142080A1 (es) 2014-12-24
CN107647394A (zh) 2018-02-02
US20130089638A1 (en) 2013-04-11
RU2014110708A (ru) 2015-11-20
MX2014004060A (es) 2014-07-09
CO6940418A2 (es) 2014-05-09
BR112014008498A2 (pt) 2017-04-11
CA2852109A1 (en) 2013-04-18
ECSP14000460A (es) 2015-06-30
TW201822640A (zh) 2018-07-01
WO2013055463A1 (en) 2013-04-18
TW201325460A (zh) 2013-07-01
EP2765872A1 (en) 2014-08-20
AR088035A1 (es) 2014-05-07
CN103929979A (zh) 2014-07-16
HK1250315A1 (zh) 2018-12-14

Similar Documents

Publication Publication Date Title
HK1256896A1 (zh) 用於實現多重cold-pcr的方法和組合物
IL231227A0 (en) Compounds and preparations as kit inhibitors - c
IL231226A0 (en) Compounds and preparations as kit inhibitors - c
PT2744765T (pt) Ternesite como aditivo de cimento portland
EP2694686A4 (en) COMPOSITION AND METHOD FOR MODIFYING 5-METHYLCYTOSINE (5MC)
SG11201400213QA (en) Poly alpha olefin compositions and process to produce poly alpha olefin compositions
SG10201504780PA (en) Semiconductor device and method of formingextended semiconductor device with fan-outinterconnect structure to reduce complexity ofsubstrate
EP2675471A4 (en) HSA-RELATED COMPOSITIONS AND USE PROCESSES
HK1212251A1 (en) Topical compositions and methods of use
SG10201602147YA (en) Methods And Compositions For Predicting Response To Eribulin
EP2892315A4 (en) METHODS AND COMPOSITIONS REDUCING THE WATER-REPELLING CHARACTER OF SOIL
EP2968244A4 (en) COMPOSITIONS AND METHODS FOR USING ALIGAL COMPOUNDS
HK1198387A1 (zh) 用作黃病毒科病毒抑制物之噻吩- -羧酸衍生物
GB2502915B (en) Radiation-induced thickening for set-on-command sealant compositions and methods of use
EP2691105A4 (en) METHODS AND COMPOSITIONS ASSOCIATED WITH INHIBITION OF VIRUS INPUT
EP2683411A4 (en) METHODS OF USING MICROARN-26A FOR PROMOTING ANGIOGENESIS
ME02167B (me) Piridinil- i pirazinil-metiloksi-aril derivati korisni kao inhibitori tirozin kinaze slezine (syk)
IL236692B (en) A method for inducing cells into a less mature state
HK1250315A1 (zh) 包含麥芽三糖的組合物及其用於抑制脫水所致損傷的用途
HK1198657A1 (en) Addition of iron to improve cell culture
EP2751071A4 (en) Fatty Acid Amide, Compositions Thereof and Method of Use Therefor
GB201113596D0 (en) Compounds, compositions and methods to promote oligodendrogenesis and remyelination
TWM386035U (en) Structure of anvil block to prevent slipping
HRP20150141T1 (en) Use of nifuratel to treat infections caused by clostridium species
IL239623A0 (en) Methods and preparations for administering oxybutynin